About Fortis Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
3
Hoffmann-La Roche
2
Indian Society of Critical Care Medicine
1
Janssen Research & Development, LLC
1
Sopherion Therapeutics
1
Tata Memorial Centre
1
Clinical Trials at Fortis Hospital
During the past decade, Fortis Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy
2010-10-26
2015-01-01
Completed
110
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Fortis Hospital" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "Indian Society of Critical Care Medicine" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Sopherion Therapeutics"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fortis Hospital"
#1 collaborator was "Indian Society of Critical Care Medicine" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Fortis Hospital
According to Clinical.Site data, the most researched conditions in "Fortis Hospital" are
"Ulcerative Colitis" (3 trials), "Breast Cancer" (1 trials), "Critical Illness" (1 trials), "Crohn's Disease" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Fortis Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Fortis Hospital
Most popular intervention types in "Fortis Hospital" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Mirikizumab" (2 trials), "Placebo" (2 trials), "Guselkumab" (1 trials), "Guselkumab Dose 1" (1 trials) and "Guselkumab Dose 2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fortis Hospital
The vast majority of trials in "Fortis Hospital" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Fortis Hospital
Currently, there are NaN active trials in "Fortis Hospital".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Fortis Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fortis Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".